BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32286604)

  • 1. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
    Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
    Radif Y; Ndiaye H; Kalantzi V; Jacobs R; Hall A; Minogue S; Waugh MG
    Mol Cell Biochem; 2018 Nov; 448(1-2):275-286. PubMed ID: 29450800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
    Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
    Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
    Ansari IH; Longacre MJ; Stoker SW; Kendrick MA; O'Neill LM; Zitur LJ; Fernandez LA; Ntambi JM; MacDonald MJ
    Arch Biochem Biophys; 2017 Mar; 618():32-43. PubMed ID: 28193492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cells.
    Poppelreuther M; Sander S; Minden F; Dietz MS; Exner T; Du C; Zhang I; Ehehalt F; Knüppel L; Domschke S; Badenhop A; Staudacher S; Ehehalt R; Stremmel W; Thiele C; Heilemann M; Füllekrug J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):614-624. PubMed ID: 29526665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers.
    Yang Y; Zhu T; Wang X; Xiong F; Hu Z; Qiao X; Yuan X; Wang D
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
    Wu M; Cao A; Dong B; Liu J
    Int J Mol Med; 2011 May; 27(5):655-62. PubMed ID: 21347510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characterization, Tissue Distribution Profile, and Nutritional Regulation of
    Yang Z; Zhu H; Huang X; Wang A; Xie D
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntaxin 17 promotes lipid droplet formation by regulating the distribution of acyl-CoA synthetase 3.
    Kimura H; Arasaki K; Ohsaki Y; Fujimoto T; Ohtomo T; Yamada J; Tagaya M
    J Lipid Res; 2018 May; 59(5):805-819. PubMed ID: 29549094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
    Bu SY; Mashek MT; Mashek DG
    J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake.
    Poppelreuther M; Rudolph B; Du C; Großmann R; Becker M; Thiele C; Ehehalt R; Füllekrug J
    J Lipid Res; 2012 May; 53(5):888-900. PubMed ID: 22357706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.
    Sun XJ; Xu GL
    Med Sci Monit; 2017 Sep; 23():4343-4350. PubMed ID: 28887439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
    Feng J; Lu PZ; Zhu GZ; Hooi SC; Wu Y; Huang XW; Dai HQ; Chen PH; Li ZJ; Su WJ; Han CY; Ye XP; Peng T; Zhou J; Lu GD
    Acta Pharmacol Sin; 2021 Jan; 42(1):160-170. PubMed ID: 32541921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.
    Van Horn CG; Caviglia JM; Li LO; Wang S; Granger DA; Coleman RA
    Biochemistry; 2005 Feb; 44(5):1635-42. PubMed ID: 15683247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol.
    Küch EM; Vellaramkalayil R; Zhang I; Lehnen D; Brügger B; Sreemmel W; Ehehalt R; Poppelreuther M; Füllekrug J
    Biochim Biophys Acta; 2014 Feb; 1841(2):227-39. PubMed ID: 24201376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α induces acyl-CoA synthetase 3 to promote lipid droplet formation in human endothelial cells.
    Jung HS; Shimizu-Albergine M; Shen X; Kramer F; Shao D; Vivekanandan-Giri A; Pennathur S; Tian R; Kanter JE; Bornfeldt KE
    J Lipid Res; 2020 Jan; 61(1):33-44. PubMed ID: 31722970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment.
    Toshida K; Itoh S; Iseda N; Tomiyama T; Yoshiya S; Toshima T; Liu YC; Iwasaki T; Okuzaki D; Taniguchi K; Oda Y; Mori M; Yoshizumi T
    Liver Int; 2024 Apr; 44(4):1011-1023. PubMed ID: 38293713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.